Ftse Mib
34.492,41
0,13%
DAX
18.497,94
-0,09%
S&P 500
5.277,51
0,80%
NASDAQ
16.735,02
-0,01%
Bitcoin
67.529,57
0,07%
Registration Strip Icon for alerts Registrati per avvisi in tempo reale, portafoglio personalizzato e movimenti di mercato.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Lifecore Biomedical Inc (LFCR) Lifecore Biomedical Inc (LFCR) Notizie

Lifecore Biomedical Inc

LFCR
5,84
0,06 (1,04%)
31 Mag 2024 - Chiuso
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
22/5/202423:48EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22/5/202423:43EDGAR2Form 3 - Initial statement of beneficial ownership of..
22/5/202422:30EDGAR2Form 8-K - Current report
22/5/202422:16GLOBELifecore Announces Inducement Grants Under Nasdaq Listing..
20/5/202422:32EDGAR2Form SC 13D/A - General statement of acquisition of..
16/5/202422:48EDGAR2Form 8-K - Current report
16/5/202422:45GLOBELifecore Biomedical Completes Incremental Liquidity..
08/5/202423:19EDGAR2Form 8-K - Current report
07/5/202422:48EDGAR2Form 8-K - Current report
19/4/202422:30GLOBELifecore Biomedical, Inc. Receives Notice from Nasdaq..
01/4/202414:00GLOBELifecore Biomedical Provides Business Update Outlining..
26/3/202421:30GLOBELifecore Biomedical Announces Pending Change of Auditor and..
20/3/202412:30GLOBELifecore Biomedical Concludes Strategic Evaluation Process,..
20/3/202412:00GLOBELifecore Biomedical Completes Restatements and Files Form..
29/2/202422:25EDGAR2Form SC 13D/A - General statement of acquisition of..
16/2/202422:12EDGAR2Form 8-K - Current report
16/2/202422:05GLOBELifecore Biomedical, Inc. Announces Receipt of Nasdaq Notice..
14/2/202421:39EDGAR2Form SCHEDULE 13G - Statement of acquisition of beneficial..
03/2/202401:02EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/2/202400:41EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/2/202400:40EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/2/202400:35EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/2/202400:33EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/2/202400:31EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/2/202400:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22/1/202420:26EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/1/202422:51EDGAR2Form 8-K - Current report
12/1/202422:43GLOBELifecore Biomedical, Inc. Receives Notice from Nasdaq..
11/1/202401:14EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/1/202423:22EDGAR2Form NT 10-Q - Notification of inability to timely file Form..
05/1/202422:09EDGAR2Form 8-K - Current report
05/1/202414:00GLOBELifecore Biomedical Expands Relationship with Existing..
04/1/202422:00EDGAR2Form SC 13D/A - General statement of acquisition of..
13/12/202313:30GLOBELifecore Biomedical Provides Business Update
20/11/202322:09EDGAR2Form 8-K - Current report
20/11/202322:05GLOBECompany Reaches Favorable Resolution Regarding..
31/10/202311:17EDGAR2Form 8-K - Current report
18/10/202322:07EDGAR2Form 8-K - Current report
18/10/202322:05GLOBELifecore Biomedical, Inc. Receives Notice from Nasdaq..
17/10/202311:00PRNCASHL Medical and Lifecore Biomedical enter co-marketing..
10/10/202322:07EDGAR2Form NT 10-Q - Notification of inability to timely file Form..
10/10/202322:05GLOBELifecore Biomedical Provides Update for Development..
31/8/202313:39EDGAR2Form 8-K - Current report
31/8/202313:30GLOBELifecore Biomedical Reports Fourth Quarter and Full Fiscal..
22/8/202322:11EDGAR2Form 8-K - Current report
22/8/202322:06GLOBELifecore Biomedical Sets Fourth Quarter 2023 Earnings..
22/8/202322:05GLOBELifecore Biomedical, Inc. Receives Notice from Nasdaq..
15/8/202323:07EDGAR2Form SC 13D/A - General statement of acquisition of..
14/8/202322:11EDGAR2Form NT 10-K - Notification of inability to timely file Form..
07/7/202322:35EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
Apertura: 5,85 Min: 5,67 Max: 5,99
Chiusura: 5,78

La tua Cronologia

NASDAQ
LFCR
Lifecore Biomedical
USOTC
GELEF
Graphano Energy (QB)
TSXV
MPE
USOTC
TKPTF
Takara Printing (PK)
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network